Bayer today issued the following statement on the Eleventh Circuit’s decision in the Carson case.
The Washington Legal Foundation filed an amicus brief in support of Monsanto’s petition to the Supreme Court for review of the Pilliod decision.
Today Monsanto filed a petition for certiorari with the U.S. Supreme Court in its appeal of the Pilliod verdict. Bayer’s statement on the filing is as follows.
Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.
Read about the five-point plan here.